28733841|t|Analgosedation of adult patients with elevated intracranial pressure : Survey of current clinical practice in Austria.
28733841|a|BACKGROUND: Analgesia and sedation are key items in intensive care. Recently published S3 guidelines specifically address treatment of patients with elevated intracranial pressure. METHODS: The Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine carried out an online survey of neurointensive care units in Austria in order to evaluate the current state of practice in the areas of analgosedation and delirium management in this high-risk patient group. RESULTS: The response rate was 88%. Induction of anesthesia in patients with elevated intracranial pressure is carried out with propofol/fentanyl/rocuronium in >80% of the intensive care units (ICU), 60% use midazolam, 33.3% use esketamine, 13.3% use barbiturates and 6.7% use etomidate. For maintenance of analgosedation up to 72 h, propofol is used by 80% of the ICUs, followed by remifentanil (46.7%), sufentanil (40%) and fentanyl (6.7%). For long-term sedation, 86.7% of ICUs use midazolam, 73.3% sufentanil and 73.3% esketamine. For sedation periods longer than 7 days, 21.4% of ICUs use propofol. Reasons for discontinuing propofol are signs of rhabdomyolysis (92.9%), green urine, elevated liver enzymes (71.4% each) and elevated triglycerides (57.1%). Muscle relaxants are only used during invasive procedures. Inducing a barbiturate coma is rated as a last resort by 53.3% of respondents. The monitoring methods used are bispectral index (BIS , 61.5% of ICUs), somatosensory-evoked potentials (SSEP, 53.8%), processed electroencephalography (EEG, 38.5%), intraparenchymal partial pressure of oxygen (pO2, 38.5%) and microdialysis (23.1%). Sedation and analgesia are scored using the Richmond agitation and sedation score (RASS, 86.7%), sedation agitation scale (SAS, 6.7%) or numeric rating scale (NRS, 50%) and behavioral pain scale (BPS, 42.9%), visual analogue scale (VAS), critical care pain observation tool (CCPOT, each 14.3%) and verbal rating scale (VRS, 7.1%). Delirium monitoring is done using the confusion assessment method for intensive care units (CAM-ICU, 46.2%) and intensive care delirium screening checklist (ICDSC, 7.7%). Of the ICUs 46.2% do not carry out delirium monitoring. CONCLUSION: We found good general compliance with the recommendations of the current S3 guidelines. Room for improvement exists in monitoring and the use of scores to detect delirium.
28733841	24	32	patients	Species	9606
28733841	38	68	elevated intracranial pressure	Disease	MESH:D019586
28733841	254	262	patients	Species	9606
28733841	268	298	elevated intracranial pressure	Disease	MESH:D019586
28733841	546	554	delirium	Disease	MESH:D003693
28733841	584	591	patient	Species	9606
28733841	662	670	patients	Species	9606
28733841	676	706	elevated intracranial pressure	Disease	MESH:D019586
28733841	727	735	propofol	Chemical	MESH:D015742
28733841	736	744	fentanyl	Chemical	MESH:D005283
28733841	745	755	rocuronium	Chemical	MESH:D000077123
28733841	807	816	midazolam	Chemical	MESH:D008874
28733841	828	838	esketamine	Chemical	MESH:C000629870
28733841	850	862	barbiturates	Chemical	MESH:D001463
28733841	876	885	etomidate	Chemical	MESH:D005045
28733841	933	941	propofol	Chemical	MESH:D015742
28733841	982	994	remifentanil	Chemical	MESH:D000077208
28733841	1004	1014	sufentanil	Chemical	MESH:D017409
28733841	1025	1033	fentanyl	Chemical	MESH:D005283
28733841	1084	1093	midazolam	Chemical	MESH:D008874
28733841	1101	1111	sufentanil	Chemical	MESH:D017409
28733841	1122	1132	esketamine	Chemical	MESH:C000629870
28733841	1193	1201	propofol	Chemical	MESH:D015742
28733841	1229	1237	propofol	Chemical	MESH:D015742
28733841	1251	1265	rhabdomyolysis	Disease	MESH:D012206
28733841	1337	1350	triglycerides	Chemical	MESH:D014280
28733841	1430	1446	barbiturate coma	Chemical	-
28733841	1701	1707	oxygen	Chemical	MESH:D010100
28733841	1801	1810	agitation	Disease	MESH:D011595
28733841	1854	1863	agitation	Disease	MESH:D011595
28733841	1932	1936	pain	Disease	MESH:D010146
28733841	2000	2004	pain	Disease	MESH:D010146
28733841	2079	2087	Delirium	Disease	MESH:D003693
28733841	2206	2214	delirium	Disease	MESH:D003693
28733841	2285	2293	delirium	Disease	MESH:D003693
28733841	2480	2488	delirium	Disease	MESH:D003693
28733841	Negative_Correlation	MESH:D005283	MESH:D019586
28733841	Negative_Correlation	MESH:C000629870	MESH:D019586
28733841	Negative_Correlation	MESH:D015742	MESH:D012206
28733841	Negative_Correlation	MESH:D015742	MESH:D019586
28733841	Negative_Correlation	MESH:D000077123	MESH:D019586
28733841	Negative_Correlation	MESH:D001463	MESH:D019586
28733841	Negative_Correlation	MESH:D000077208	MESH:D019586
28733841	Negative_Correlation	MESH:D008874	MESH:D019586
28733841	Negative_Correlation	MESH:D005045	MESH:D019586
28733841	Negative_Correlation	MESH:D017409	MESH:D019586

